December 1, 2016: Sarah Emond, MPP, Chief Operating Officer of ICER, will participate in the National Health Council’s Washington Representatives Retreat.
December 6, 2016: Dan Ollendorf, PhD, Chief Scientific Officer of ICER, will present on “What Price is Right? A Brief History of Value Assessment for Pharmaceuticals” at the Harvard School of Public Health’s Navigating the American Pharmaceutical Sector: Policy, Politics, Pricing, and Payment event.
December Key Dates
Ongoing until December 21, 2016: Public comments being accepted on the Multiple Sclerosis Draft Evidence Report
December 5, 2016: Draft Scoping Document on Osteoporosis posted
- December 5- December 23, 2016: Public comment period on Draft Scoping Document for Osteoporosis
December 12, 2016: Revised Scoping Document on Atopic Dermatitis posted